Emergent BioSolutions | 债务



金融业
股票价格
USD
资产
USD 1.82B
现金及等价物
USD 111.7M
销售成本
USD 381.2M
流动资产
USD 679.5M
流动负债
USD 651.3M
债务
USD 903.2M
股息收益率
0
EBIT
USD -148.1M
EBITDA
USD -113.5M
员工
1.6K
EPS每股收益
USD -0.77
股本和储备
USD 649.3M
销售毛利
USD 10M
债务利息支出
USD 17.9M
贷款资金
USD 446.5M
市值
USD 120.6M
净收入
USD -261.3M
营业费用
USD 555.9M
营业利润
USD -218M
普通股股本
USD 100K
PE价格收益
14.4
税前利润
USD -130.8M
销售收入
USD 276.6M
销售和管理费用
USD 182.8M
股票
USD 328.9M
贸易债权人
USD 112.2M
应收帐款人
USD 290.1M


债务 更改 日
Acadia Pharmaceuticals USD 56.29M 1.36M 2025-06
Akebia Therapeutics USD 46.51M 7.82M 2025-03
ALKERMES USD 71.6M 1.08M 2025-09
Alnylam Pharmaceuticals USD 1.31B 11.39M 2025-09
Amarin USD 0 0 2025-03
ANI Pharmaceuticals USD 620.31M 1.25M 2025-09
BioMarin Pharmaceutical USD 603.87M 8.22M 2025-06
Coherus Biosciences USD 294.92M 1.25M 2025-03
Emergent BioSolutions USD 903.2M 495.2M 2023-06
Exact Sciences USD 2.34B 15.24M 2025-09
Exelixis USD 176.46M 3.38M 2025-09
Glaxosmithkline GBP 17.75B 396M 2025-09
Heron Therapeutics USD 149.65M 157K 2024-09
Ionis Pharmaceuticals USD 1.23B 192.99M 2025-09
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
Lexicon Pharmaceuticals USD 99.26M 493K 2023-09
Lonza CHF 4.71B 915M 2024-12
Merck USD 41.37B 5.97B 2025-09
Moderna USD 734M 7M 2025-09
Myriad Genetics USD 59.3M 19.7M 2025-03
Nektar Therapeutics USD 0 0 2022-06
Neurocrine Biosciences USD 428.4M 10.7M 2025-09
Pacira USD 376.72M 203.77M 2025-09
Pfizer USD 60.85B 78M 2025-09
PTC Therapeutics USD 286.32M 306K 2025-09
Sanofi EUR 21.76B 530M 2025-09
Sarepta Therapeutics USD 1.35B 215.59M 2025-06
United Therapeutics USD 200M 100M 2025-03
Vanda Pharmaceuticals USD 4.96M 4.96M 2024-12
Xoma USD 120.79M 3.27M 2024-06


Emergent BioSolutions 债务 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.